- Filed
- May 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 94.92M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 94.92M sh |
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 94.92M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$1.79M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$607.21K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $270.48K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $424.59K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$4.56M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$3.12M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.33M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.6M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $13.92M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $12.94M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.2M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.29M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.36M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.82M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.02 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.02 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Net Income | Q1 2025 · Mar 31, 2025 | −$1.44M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$854.2K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$1.33M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$862.16K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $601.38K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $767.75K |
| Revenue | Q1 2025 · Mar 31, 2025 | $7.18M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $5.89M |